US drug companies are preparing for new draconian provisions for reporting on financial relationships with academia. Will efforts to increase transparency prove burdensome to researchers and the industry? Virginia Hughes investigates.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research
BMC Research Notes Open Access 31 January 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rockey, S.J. & Collins, F.S. J. Am. Med. Assoc. published online, doi: 10.1001/jama.2010.774 (24 May 2010).
Levinson, D. CDC's ethics program for special government employees on federal advisory committees (CDC, Atlanta, Georgia, December, 2009). http://oig.hhs.gov/oei/reports/oei-04-07-00260.pdf
Campbell, E.G. et al. J. Am. Med. Assoc. 298, 1779–1786 (2007).
Contopoulos-Ioannidis, D.G. et al. Am. J. Med. 114, 477–484 (2003).
Wazana, A. J. Am. Med. Assoc. 283, 373–380 (2000).
Choudhry, N.K. et al. J. Am. Med. Assoc. 287, 612–617 (2002).
Bekelman, J.E. et al. J. Am. Med. Assoc. 289, 454–465 (2003).
Turner, E.H. et al. N. Engl. J. Med. 358, 252–260 (2008).
Okike, K. et al. N. Engl. J. Med. 361, 1466–1474 (2009).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hughes, V. Sunshine on conflicts. Nat Biotechnol 28, 641–643 (2010). https://doi.org/10.1038/nbt0710-641
Issue Date:
DOI: https://doi.org/10.1038/nbt0710-641
This article is cited by
-
Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research
BMC Research Notes (2011)
-
Crossing the line
Nature Biotechnology (2010)
